Taiwan Biomaterial Co., Ltd. (TPEX:6649)
41.45
-0.95 (-2.24%)
Mar 5, 2026, 1:30 PM CST
Taiwan Biomaterial Market Cap
Taiwan Biomaterial has a market cap or net worth of 1.78 billion as of March 5, 2026. Its market cap has increased by 19.44% in one year.
Market Cap
1.78B
Enterprise Value
1.47B
Revenue
203.27M
Ranking
n/a
PE Ratio
31.40
Stock Price
41.45
Market Cap Chart
Since August 29, 2017, Taiwan Biomaterial's market cap has decreased from 2.34B to 1.78B, a decrease of -23.90%. That is a compound annual growth rate of -3.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 1.78B | -8.82% |
| Dec 31, 2025 | 1.95B | 35.96% |
| Dec 31, 2024 | 1.44B | 9.27% |
| Dec 29, 2023 | 1.31B | -9.80% |
| Dec 30, 2022 | 1.46B | 78.08% |
| Dec 30, 2021 | 818.40M | -16.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Aug 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| A Plus Biotechnology | 2.70B |
| Applied BioCode | 2.61B |
| Dynamic Medical Technologies | 2.33B |
| Wellell | 2.26B |
| OK Biotech | 1.97B |
| Diamond Biotechnology | 1.97B |
| Cowealth Medical Holding | 1.58B |
| Rossmax International | 1.56B |